Knowledge Center

Patent / Jan 01, 2013

Application of high dose compounds via inhalation for treatment of pulmonary diseases

Authors:
  • Pedro Mendes
  • Isabel Lopes
  • Jason Suggett
  • Phillip Nelson
Source:
WO 2013104892

The invention relates to the delivery of high doses of active pharmaceutical compds. via inhalation for the treatment of pulmonary diseases. A pharmaceutical formulation in the form of a powder suitable for inhalation comprises one or more active pharmaceutical ingredients, such as an antibiotic, a mucolytic agent and/or a buffer, wherein the formulation is free of carrier. A powder formulation comprising doxycycline monohydrate combined with sodium citrate filled into TwinCap devices was exemplified.

Also in the Knowledge Center

Related Content

Hovione Policies

Hovione is dedicated to serving the Pharma Industry by providing services and products that save human lives and improve quality of life. Our team is fully committed to our Quality, HSEEn, HR and Innovation & Entrepreneurship policies.

Page
Read more

Cryogenics

Hovione has experience in carrying out reactions at low temperatures.

Page
Read more

Drug Substance Development

Talented people, smart processes and cutting-edge equipment – we have the perfect formula to meet all your process development and scale-up needs.

Page
Read more